51.41
price up icon2.74%   1.37
after-market Handel nachbörslich: 51.60 0.19 +0.37%
loading
Schlusskurs vom Vortag:
$50.04
Offen:
$49.81
24-Stunden-Volumen:
483.62K
Relative Volume:
0.51
Marktkapitalisierung:
$5.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-746.61M
KGV:
-6.8822
EPS:
-7.47
Netto-Cashflow:
$-485.24M
1W Leistung:
+0.90%
1M Leistung:
+7.94%
6M Leistung:
+26.35%
1J Leistung:
+66.81%
1-Tages-Spanne:
Value
$49.48
$51.42
1-Wochen-Bereich:
Value
$48.73
$51.61
52-Wochen-Spanne:
Value
$26.80
$62.21

Biohaven Ltd Stock (BHVN) Company Profile

Name
Firmenname
Biohaven Ltd
Name
Telefon
203-404-0410
Name
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Name
Mitarbeiter
239
Name
Twitter
@biohavenpharma
Name
Nächster Verdiensttermin
2022-11-07T13:30:00.000Z
Name
Neueste SEC-Einreichungen
Name
BHVN's Discussions on Twitter

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-16 Eingeleitet Jefferies Buy
2024-09-04 Eingeleitet Bernstein Outperform
2024-07-24 Eingeleitet Morgan Stanley Overweight
2024-02-16 Eingeleitet RBC Capital Mkts Outperform
2024-02-06 Eingeleitet UBS Buy
2023-12-22 Eingeleitet H.C. Wainwright Buy
2023-12-08 Eingeleitet Robert W. Baird Outperform
2023-01-24 Eingeleitet SVB Securities Outperform
2023-01-04 Eingeleitet JP Morgan Overweight
2022-12-02 Eingeleitet BTIG Research Buy
2022-10-26 Hochstufung Cantor Fitzgerald Neutral → Overweight
2022-10-12 Eingeleitet Piper Sandler Overweight
2022-08-19 Herabstufung Piper Sandler Overweight → Neutral
2022-08-08 Herabstufung Wedbush Outperform → Neutral
2022-05-11 Herabstufung SVB Leerink Outperform → Mkt Perform
2021-10-19 Fortgesetzt Morgan Stanley Equal-Weight
2021-08-10 Herabstufung UBS Buy → Neutral
2021-08-03 Bestätigt Canaccord Genuity Buy
2021-03-11 Eingeleitet UBS Buy
2020-12-15 Eingeleitet H.C. Wainwright Buy
2020-04-17 Eingeleitet Cowen Outperform
2020-02-10 Herabstufung Oppenheimer Outperform → Perform
2020-02-06 Eingeleitet Mizuho Buy
2019-11-22 Eingeleitet Wedbush Outperform
2019-06-25 Bestätigt Canaccord Genuity Buy
2019-05-06 Eingeleitet Goldman Buy
2019-04-09 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-03-04 Bestätigt Needham Buy
2018-07-03 Bestätigt Needham Buy
2018-07-02 Bestätigt Needham Buy
2018-04-05 Herabstufung Barclays Overweight → Equal Weight
2018-02-22 Bestätigt Canaccord Genuity Buy
2017-12-15 Eingeleitet Canaccord Genuity Buy
2017-10-03 Bestätigt Needham Buy
Alle ansehen

Biohaven Ltd Aktie (BHVN) Neueste Nachrichten

pulisher
02:11 AM

Vanguard Group Inc's Strategic Acquisition in Biohaven Ltd - GuruFocus.com

02:11 AM
pulisher
Oct 31, 2024

(BHVN) Technical Data - Stock Traders Daily

Oct 31, 2024
pulisher
Oct 20, 2024

Cadent Capital Advisors LLC Invests $1.77 Million in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

(BHVN) Trading Advice - Stock Traders Daily

Oct 20, 2024
pulisher
Oct 16, 2024

Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com India

Oct 16, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

BofA sustains Buy rating on Biohaven shares, sees SMA trial upside - Investing.com UK

Oct 15, 2024
pulisher
Oct 13, 2024

Biohaven Ltd. (NYSE:BHVN) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Oct 13, 2024
pulisher
Oct 11, 2024

Biohaven: A Complicated Tale (NYSE:BHVN) - Seeking Alpha

Oct 11, 2024
pulisher
Oct 10, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Acquired by AQR Capital Management LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

(BHVN) Investment Analysis - Stock Traders Daily

Oct 09, 2024
pulisher
Oct 09, 2024

17,064 Shares in Biohaven Ltd. (NYSE:BHVN) Acquired by Squarepoint Ops LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Biohaven retains Outperform stock rating on clinical results By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven holds steady with $60 target on SMA trial optimism By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven maintains Buy rating with $59 target amid SMA trial optimism By Investing.com - Investing.com South Africa

Oct 07, 2024
pulisher
Oct 07, 2024

Biohaven (NYSE:BHVN) Stock Price Up 4.9%Here's What Happened - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Vladimir Coric Buys Handful Of Shares In Biohaven - Simply Wall St

Oct 06, 2024
pulisher
Oct 04, 2024

Biohaven Stock Soars on Drug Trial Results: Time to Jump In? - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise - MSN

Oct 04, 2024
pulisher
Oct 04, 2024

Analysts’ Recent Ratings Changes for Biohaven (BHVN) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Price Target Raised to $68.00 at JPMorgan Chase & Co. - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven (NYSE:BHVN) Shares Gap Up After Insider Buying Activity - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

John W. Childs Purchases 21,052 Shares of Biohaven Ltd. (NYSE:BHVN) Stock - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Bullish Biohaven Insiders Loaded Up On US$41.7m Of Stock - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven director Childs buys shares worth nearly $1 million - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Biohaven CEO Vlad Coric acquires $999,970 in company stock - Investing.com India

Oct 03, 2024
pulisher
Oct 03, 2024

Marshall Wace LLP Sells 677,724 Shares of Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Lelezard.com

Oct 02, 2024
pulisher
Oct 02, 2024

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven shares could see growth as MDD and bipolar studies advance, per TD Cowen - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven (NYSE:BHVN) Sees Strong Trading Volume - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven sets public offering price at $47.50 per share - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven down after $250 mln stock offering prices - XM

Oct 01, 2024
pulisher
Oct 01, 2024

Biohaven Announces Pricing of $250 Million Public Offering of Common Shares - Nasdaq

Oct 01, 2024
pulisher
Sep 30, 2024

Biohaven launches $250 million public stock offering By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 30, 2024

After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven launches $250 million public stock offering - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven Announces Proposed Public Offering of Common Shares - PR Newswire

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven starts phase 2 trial for new migraine treatment - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven starts phase 2 trial for new migraine treatment By Investing.com - Investing.com UK

Sep 30, 2024
pulisher
Sep 30, 2024

Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine - PR Newswire

Sep 30, 2024
pulisher
Sep 30, 2024

Driehaus Capital Management LLC Lowers Stake in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Indo-Asian News Service - IANS India Pvt Ltd

Sep 29, 2024
pulisher
Sep 29, 2024

Biohaven, Tesla And Other Big Stocks Moving Higher On Monday - MSN

Sep 29, 2024
pulisher
Sep 29, 2024

97,902 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Cubist Systematic Strategies LLC - Defense World

Sep 29, 2024

Finanzdaten der Biohaven Ltd-Aktie (BHVN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):